NCT05790265 is a NA clinical trial of ANNE One in Blood Pressure, sponsored by Sibel Health Inc..

Who is sponsoring NCT05790265?

NCT05790265 is sponsored by Sibel Health Inc..

What drugs are being tested in NCT05790265?

Interventions in NCT05790265: ANNE One.

What condition does NCT05790265 study?

NCT05790265 studies Blood Pressure.

Is NCT05790265 still recruiting?

NCT05790265 is currently status unknown. Last updated 30 March 2023.

Last reviewed 2023-03-30 · How we verify

NCT05790265

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Assessing Innovative Wireless and Wearable Sensors for Continuous Blood Pressure Measurement in Obese Pregnant Women

Status unknown NA Last updated 30 March 2023

What this trial tests

NA trial testing ANNE One in Blood Pressure in 20 participants. Status unknown.

Timeline

1 May 2023

Primary endpoint
31 December 2023

31 December 2023

Quick facts

Lead sponsor	Sibel Health Inc.
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	20
Start date	1 May 2023
Primary completion	31 December 2023
Estimated completion	31 December 2023

Drugs / interventions tested

ANNE One

Conditions studied

Blood Pressure — all drugs for Blood Pressure →

Sponsor

Sibel Health Inc.

Who can join

18 and older, female only, with Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a prospective study targeting at least 20 obese and super-obese patients admitted to Labor \& Delivery (L\&D) for delivery at UNC Medical Center. Patients with clinical indicated radial A-lines either planned or already in-situ will be offered participation. The study will evaluate the accuracy of noninvasive blood pressure measurements with the ANNE One system to blood pressure readings with the radial A-line.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of ANNE One

Trials testing the same drug.

NCT04635787 — Vital Sensor Monitors for CV19 Detection · completed

Other recruiting trials for Blood Pressure

Currently open trials in the same condition.

NCT07070583 — Impact of Aorto-Iliac Occlusive Disease Treatment on Blood Pressure · NA · recruiting
NCT07396636 — Machine Learning-Assisted Management of Intraoperative Hypotension for Personalized Treatment · recruiting
NCT06719518 — Performance Evaluation of the ViTrack Continuous Non-invasive Blood Pressure Measurement Device · recruiting
NCT07319117 — Evaluation of the Impact of a Nutritional Formulation on Cognitive Performance Following Stress Exposure. · NA · recruiting
NCT06837181 — Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM) · recruiting

Other Sibel Health Inc. trials

Trials by the same sponsor.

NCT05693168 — Accuracy of Pulse Oximeter With Profound Hypoxia · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05790265 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Sibel Health Inc.
Last refreshed: 30 March 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05790265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing